AtaiBeckley (ATAI) Net Margin (2021 - 2026)

AtaiBeckley's quarterly Net Margin came in at 3121.8% in Q1 2026, down 142206.0% year-on-year from N/an in Q1 2025, and down 83.66% quarter-over-quarter from 1699.74% in Q1 2025.

AtaiBeckley's Net Margin history runs 5 years deep, the most recent figure standing at 8154.07% for Q3 2025.

  • In Q3 2025, Net Margin rose 5756093.0% year-over-year to 8154.07%; the TTM figure through Sep 2025 stood at 5080.46% (up 3377241.0% YoY), while the FY2024 annual figure was 48463.96%, down 3565377.0% from the prior year.
  • Net Margin for Q1 2026 stood at 3121.8%, down from 1699.74% in the prior quarter.
  • The five-year high for Net Margin was 1699.74% in Q1 2025, with the low at 3121.8% in Q1 2026.
  • A 5-year average of 56261.37% and a median of 21266.7% in 2022 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin surged 19205101 bps in 2023 and slumped 22302778 bps in 2024, its largest moves.
  • AtaiBeckley's Net Margin stood at 22667.83% in 2021, then sank by 423 bps to 118450.0% in 2022, then advanced by 14 bps to 101622.22% in 2023, then sank by 219 bps to 324650.0% in 2024, then jumped by 97 bps to 8154.07% in 2025.
  • According to Business Quant data, Net Margin over the past three periods registered 8154.07%, 3856.61%, and 1699.74% for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 AtaiBeckley 1.62 Bn 1.62 Bn - -3,121.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,121.80%
Sep 30, 2025 -8,154.07%
Jun 30, 2025 -3,856.61%
Mar 31, 2025 -1,699.74%
Mar 31, 2025 -1,699.74%
Dec 31, 2024 -324,650.00%
Sep 30, 2024 -65,715.00%
Jun 30, 2024 -20,993.41%
Dec 31, 2023 -101,622.22%
Sep 30, 2023 50,855.17%
Jun 30, 2023 -19,210.47%
Mar 31, 2023 -89,554.05%
Dec 31, 2022 -118,450.00%
Sep 30, 2022 -141,195.83%
Jun 30, 2022 -21,540.00%
Dec 31, 2021 -22,667.83%
Sep 30, 2021 -11,713.53%
Mar 31, 2021 -14.37%